A.I.dvisor tells us that INCR and ACB have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and ACB's prices will move in lockstep.
| Ticker / NAME | Correlation To INCR | 1D Price Change % | ||
|---|---|---|---|---|
| INCR | 100% | +1.20% | ||
| ACB - INCR | 25% Poorly correlated | +0.44% | ||
| SNDL - INCR | 25% Poorly correlated | +4.12% | ||
| CRON - INCR | 24% Poorly correlated | +2.15% | ||
| AKAN - INCR | 24% Poorly correlated | -4.10% | ||
| DVAX - INCR | 23% Poorly correlated | -0.37% | ||
More | ||||
| Ticker / NAME | Correlation To INCR | 1D Price Change % |
|---|---|---|
| INCR | 100% | +1.20% |
| Pharmaceuticals: Generic industry (213 stocks) | 17% Poorly correlated | +1.09% |